Fundamental Analysis
52 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -1.0% | -0.1% | 2 / 3 | -6.6% | +1.13 pp | +0.38 pp | +27.8% | 0.00 | 14.02 | 178 | −6,6% | 11,9 | −1,0% | 14.02 | 15.01 | −6,6% |
| Pts | 0 | 0 | 8 | 0 | 8 | 8 | 12 | 12 | 8 | |||||||
Valuation annotation:Price: 56.500 (close price on 2026-10-19)EPS (TTM): 4.030
Financial charts
1.Revenue & growth
VND bn178Q2/26
1.Revenue & growth
VND bn178Q2/26
2.Profit & growth
VND bn11,9Q2/26
3.Profit mix (Penman)
VND bn61,9Q2/26
4.Margins & cost structure
%20.0%Q2/26
5.Returns & cash cycle
% · days100%Q2/26
6.Earnings quality & cash
VND bn37,9Q2/26
7.Asset structure
VND bn281Q2/26
8.Funding & debt health
VND bn · times281Q2/26
9.Revenue backlog
VND bn4,78Q2/26
10.Valuation
times · %14,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %989Q2/26
Adjusted EPS growth, latest quarter
-1.0%
Average adjusted EPS growth, 3 quarters
-0.1%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26